Werner MuehelemannAllon Therapeutics Inc.NPC.TOCOMMENTMay 28, 2008

Main technology is trying to develop a drug for Alzheimer's. Have had good success to now. Still not a commercial product so there is still a lot of risk. Good potential. Has been looking at this one.

Werner Muehelemann

Unlock Rating

$1.05

Stock price when the opinion was issued

medical services

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

are in phase 2 and 3 testing for some drugs. Gotta be willing to be patient on it. Take small positions, be prepared if their testing doesn't work out to loose your money.

Most Recent Experts

Joe Hegener, CIO & Founder, Asterozoa Capital

Asterozoa Capital

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Teal Linde

Linde Equity Report

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Werner MuehelemannAllon Therapeutics Inc.NPC.TOCOMMENTMay 28, 2008

You might be interested:

Allon Therapeutics Inc.(NPC.TO)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals